Sort
261,768 grants matching “gene therapy”
Maximizing the Effectiveness of PI3K Inhibitors in the Treatment of Pten null Cancers
$1,049,779Thomas M Roberts · Dana-Farber Cancer Inst · R35 · FY2025 · CA
Maximizing the Effectiveness of PI3K Inhibitors in the Treatment of Pten null Cancers
$1,049,779Thomas M Roberts · Dana-Farber Cancer Inst · R35 · FY2021 · CA
MOLECULAR THERAPY FOR CF AND GENETIC DISEASES
$1,049,748University Of Pennsylvania · P30 · FY2004 · DK
A Novel Microbiome-Based Immune-Modulator that Potentiates Cancer Checkpoint Therapy
$1,049,717Gary Fanger · Rise Therapeutics, Llc · R44 · FY2022 · CA
Basic and Translational Studies of Cystic Fibrosis
$1,049,630Raymond A Frizzell · University Of Pittsburgh At Pittsburgh · P30 · FY2016 · DK
Studies in pig-to-primate cardiac xenotransplantation
$1,049,588Christopher G.a. Mc Gregor · Mayo Clinic Rochester · U01 · FY2011 · AI
Mechanisms of Bile Secretion and Cholestasis
$1,049,323James Lorenzen Boyer · Yale University · R37 · FY2014 · DK
In vivo studies of neural system in zebrafish
$1,049,140Fumihito Ono · National Institute On Alcohol Abuse And Alcoholism · Z01 · FY2008 · AA
Molecular Mechanisms and Treatment Of Autoimmunity In Man And Animal Models
$1,049,013Michael J Lenardo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Development of New Hypoxic Cytotoxins for Cancer Therapy
$1,049,012Stanford University · P01 · FY2004 · CA
Age-Related Macular Degeneration: Genetic Variations and Animal Model
$1,048,901Chi-Chao Chan · National Eye Institute · ZIA · FY2011 · EY
HIV-1 Integrase
$1,048,861Stephen H Hughes · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Validation of Biomarkers for predicting Barrett's esophagus that will or will not: i) progress towards cancer, or ii) recur after ablation
$1,048,823Sanford D Markowitz · Case Western Reserve University · U01 · FY2025 · CA
Synthetic Approaches to Carcinogen-Linked Oligonucleotides
$1,048,822Carmelo J Rizzo · Vanderbilt University · P01 · FY2016 · CA
Synthetic Approaches to Carcinogen-Linked Oligonucleotides
$1,048,822Carmelo J Rizzo · Vanderbilt University · P01 · FY2015 · CA
AGING DISEASE--TRANSGENIC/VIROLOGIC/IMMUNOLOGIC STUDIES
$1,048,805Scripps Research Institute · P01 · FY2001 · AG
Vif Antagonism: Lead Discovery and SAR - Project 1
$1,048,792Tariq M Rana · University Of Miami School Of Medicine · P01 · FY2017 · MH
Targeting Genetic and Metabolic Alterations in Distinct Subtypes of RCC
$1,048,777Ramaprasad Srinivasan · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Development Of Theoretical Methods For Studying Biological Macromolecules
$1,048,765Bernard R Brooks · National Heart, Lung, And Blood Institute · ZIA · FY2021 · HL
TGF-beta Regulation of Mucosal and Systemic T Cell Immunity and Tolerance
$1,048,669Wanjun Chen · National Institute Of Dental & Craniofacial Research · Z01 · FY2008 · DE
Maintenance of Models of Human Hemophilia and VWD
$1,048,483Timothy Charles Nichols · Univ Of North Carolina Chapel Hill · R24 · FY2014 · HL
Immunologic Monitoring and Cellular Products Laboratory
$1,048,441Yen-Michael S. Hsu · University Of Pittsburgh At Pittsburgh · P30 · FY2021 · CA
Determinants of inception of inflammation in inflammatory bowel diseases
$1,048,416Ashwin N Ananthakrishnan · Massachusetts General Hospital · R01 · FY2025 · DK
Sex Differences in Inflammation Across the Lifespan
$1,048,212Louise Deborah McCullough · University Of Texas Hlth Sci Ctr Houston · R35 · FY2023 · NS
Studies Of Central Nervous System Functional Anatomy
$1,048,141Miles A. Herkenham · National Institute Of Mental Health · Z01 · FY2008 · MH